Skip to Main Content

Paper Details

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer.
Clin Cancer Res
10
2021
Author NameAffiliation
Steven J IsakoffMassachusetts General Hospital Cancer Center
Steven J IsakoffHarvard Medical School
Andre SchultzMassachusetts General Hospital Cancer Center
Lisa A CareyUniversity of North Carolina at Chapel Hill
Minetta C LiuGeorgetown Lombardi Comprehensive Cancer Center
Vered StearnsJohns Hopkins University and Sidney Kimmel Cancer Center
Michael S LawrenceMassachusetts General Hospital Cancer Center
Michael S LawrenceHarvard Medical School
Michael S LawrenceBroad Institute of MIT and Harvard University
  • 1 - 9

Datasets

Release 1.2